Linked Life Data

9304232

Source:http://linkedlifedata.com/resource/pubmed/id/9304232

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7-8
pubmed:dateCreated
1997-9-25
pubmed:abstractText
Chronic administration of dopaminomimetic drugs, levodopa before all, to patients with Parkinson's disease (PD) is accompanied with numerous complications. Psychiatric complications are not only frequent, but also difficult to manage. Reduction of the daily dose or complete discontinuation of dopaminomimetic therapy and usage of conventional neuroleptic drugs may relieve the psychotic symptoms, but both these approaches are associated with unacceptable deterioration of motor symptoms. The aim of the study is to present our experience in the treatment of levodopa-induced psychoses by clozapine in patients with PD. Clozapine is a non-typical antipsychotic drug with low potential fr inducing extrapyramidal symptoms.
pubmed:language
srp
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0370-8179
pubmed:author
pubmed:issnType
Print
pubmed:volume
125
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
203-6
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:articleTitle
[Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
pubmed:publicationType
Journal Article, English Abstract